Bayforest Capital Ltd Acquires Shares of 2,833 Cardinal Health, Inc. $CAH

Bayforest Capital Ltd acquired a new position in Cardinal Health, Inc. (NYSE:CAH) in the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 2,833 shares of the company’s stock, valued at approximately $476,000.

A number of other institutional investors have also recently modified their holdings of CAH. JPMorgan Chase & Co. grew its holdings in Cardinal Health by 40.0% in the first quarter. JPMorgan Chase & Co. now owns 4,175,992 shares of the company’s stock valued at $575,327,000 after purchasing an additional 1,193,983 shares during the period. Northern Trust Corp grew its stake in Cardinal Health by 3.5% in the 1st quarter. Northern Trust Corp now owns 3,143,003 shares of the company’s stock valued at $433,012,000 after acquiring an additional 105,154 shares during the period. Wellington Management Group LLP increased its holdings in Cardinal Health by 1,666.7% in the 1st quarter. Wellington Management Group LLP now owns 2,384,192 shares of the company’s stock worth $328,470,000 after acquiring an additional 2,249,241 shares in the last quarter. Price T Rowe Associates Inc. MD raised its position in Cardinal Health by 3.3% during the first quarter. Price T Rowe Associates Inc. MD now owns 1,654,036 shares of the company’s stock worth $227,877,000 after acquiring an additional 52,714 shares during the period. Finally, Dimensional Fund Advisors LP lifted its holdings in Cardinal Health by 0.6% during the first quarter. Dimensional Fund Advisors LP now owns 1,246,788 shares of the company’s stock valued at $171,749,000 after purchasing an additional 7,940 shares in the last quarter. 87.17% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at Cardinal Health

In other news, insider Ola M. Snow sold 28,151 shares of the company’s stock in a transaction on Tuesday, August 19th. The stock was sold at an average price of $148.94, for a total value of $4,192,809.94. Following the transaction, the insider owned 15,431 shares of the company’s stock, valued at $2,298,293.14. This represents a 64.59% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO Jason M. Hollar sold 107,705 shares of the stock in a transaction on Tuesday, August 19th. The stock was sold at an average price of $148.90, for a total value of $16,037,274.50. Following the transaction, the chief executive officer owned 235,901 shares of the company’s stock, valued at approximately $35,125,658.90. This represents a 31.35% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 271,676 shares of company stock valued at $40,489,525 in the last ninety days. 0.12% of the stock is currently owned by corporate insiders.

Cardinal Health Stock Down 0.1%

Shares of CAH opened at $154.11 on Wednesday. Cardinal Health, Inc. has a 52-week low of $106.98 and a 52-week high of $168.44. The company has a market capitalization of $36.61 billion, a PE ratio of 23.89, a price-to-earnings-growth ratio of 1.30 and a beta of 0.71. The stock has a fifty day simple moving average of $151.92 and a two-hundred day simple moving average of $151.45.

Cardinal Health (NYSE:CAH) last announced its quarterly earnings results on Tuesday, August 12th. The company reported $2.08 earnings per share for the quarter, beating the consensus estimate of $2.03 by $0.05. Cardinal Health had a net margin of 0.70% and a negative return on equity of 74.45%. The firm had revenue of $60.16 billion for the quarter, compared to analysts’ expectations of $60.91 billion. During the same quarter in the previous year, the company posted $1.84 EPS. The company’s revenue was up .5% compared to the same quarter last year. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. As a group, equities analysts anticipate that Cardinal Health, Inc. will post 7.95 earnings per share for the current fiscal year.

Cardinal Health Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Wednesday, October 15th. Stockholders of record on Wednesday, October 1st will be given a dividend of $0.5107 per share. This represents a $2.04 annualized dividend and a dividend yield of 1.3%. The ex-dividend date of this dividend is Wednesday, October 1st. Cardinal Health’s payout ratio is presently 31.63%.

Analyst Upgrades and Downgrades

A number of analysts have recently commented on CAH shares. Evercore ISI cut their target price on shares of Cardinal Health from $200.00 to $190.00 and set an “outperform” rating for the company in a research note on Wednesday, August 13th. Argus set a $189.00 price objective on Cardinal Health in a research note on Friday, August 22nd. Leerink Partners raised their target price on Cardinal Health from $186.00 to $187.00 and gave the company an “outperform” rating in a research report on Monday, October 6th. Robert W. Baird boosted their price target on Cardinal Health from $197.00 to $203.00 and gave the stock an “outperform” rating in a research report on Wednesday, August 13th. Finally, Wall Street Zen downgraded Cardinal Health from a “strong-buy” rating to a “buy” rating in a research note on Saturday, August 2nd. Twelve research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to data from MarketBeat, Cardinal Health currently has an average rating of “Moderate Buy” and an average price target of $166.00.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.